Skip to main content

Month: May 2024

Riot Announces April 2024 Production and Operations Updates

Riot Produces 375 Bitcoin in April 2024 and Provides Infrastructure Updates CASTLE ROCK, Colo., May 06, 2024 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry leader in vertically integrated Bitcoin (“BTC”) mining, announces unaudited production and operations updates for April 2024. Bitcoin Production and Operations Updates for April 2024             Comparison (%)  Metric   April 2024 1 March 2024 1 April 2023   Month/Month Year/Year  Bitcoin Produced   375 425 639   -12% -41%  Average Bitcoin Produced per Day 12.5 13.7 21.3   -9% -41%  Bitcoin Held 2   8,872 8,490 7,112   4% 25%  Bitcoin Sold   – – 600   N/A N/A  Bitcoin Sales – Net Proceeds   – – $17.6 million   N/A N/A  Average Net Price per Bitcoin Sold N/A N/A $29,263   N/A N/A  Deployed...

Continue reading

Turbo Energy Files Patent Application in Spain for its Sunbox Commercial and Industrial Product

Turbo Energy’s Sunbox Commercial & Industrial (“Sunbox C&I”) ProductSource: Turbo EnergyVALENCIA, Spain, May 06, 2024 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (NASDAQ: TURB) (“Turbo Energy” or “the Company”), a leader in the field of photovoltaic energy storage, today announced it has filed a patent application with the Spanish Patent and Trademark Office (“OEPM”) for its Sunbox Commercial & Industrial (“Sunbox C&I”) product. This product, which is already available on the market, offers the most efficient and adaptable solution for both isolated and grid-connected projects. Additionally, the product allows for existing solar installations of any brand to be managed by the Sunbox system, thus expanding a user’s photovoltaic production capability as needed.Turbo Energy’s Sunbox Commercial & Industrial...

Continue reading

Portillo’s Strengthens Leadership Team with first Chief Information Officer and Chief Marketing Officer Appointments

Restaurant industry veteran Keith Correia named CIO, Nick Scarpino promoted to CMO as brand furthers growth strategyNick Scarpino, Chief Marketing Officer of Portillo’sNick Scarpino, Chief Marketing Officer of Portillo’sKeith Correia, Chief Information Officer of Portillo’sKeith Correia, Chief Information Officer of Portillo’sCHICAGO, May 06, 2024 (GLOBE NEWSWIRE) — Portillo’s (NASDAQ: PTLO), the fast-casual restaurant concept known for its menu of unrivaled Chicago-style street food, today announced the appointments of Keith Correia as Chief Information Officer (CIO) and Nick Scarpino as Chief Marketing Officer (CMO). Both leaders will play key roles for the business as Portillo’s expands and scales nationwide. “I’m thrilled to welcome Keith and Nick into their new roles as we drive Portillo’s...

Continue reading

Empowering Shareholders: AGBA’s US$4b Merger with Triller Ushers in New Era of Value Creation

LOS ANGELES, May 06, 2024 (GLOBE NEWSWIRE) — NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), the leading one-stop financial supermarket in Hong Kong reaffirms its unwavering dedication to creating shareholder value through a collaborative team effort and strategic initiatives. Since going public via a SPAC in November 2023, AGBA’s team of over 1,500+ employees has worked tirelessly everyday in delivering steady growth persistently quarter after quarter maintaining our market leadership.  At the same time, we work constantly testing and creating partnership and acquisition opportunities that would provide important long-term strategic advantages. The $4 billion merger of AGBA and Triller announced on April 18, is a direct result of such team efforts. AGBA’s shares have traded well.  As...

Continue reading

Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.

Pacific Software Inc. (OTC: PFSF) on February 26th announced the acquisition of certain business assets of Dreamaderm Inc., a pioneer in dermatological innovation. DANA POINT, Calif., May 06, 2024 (GLOBE NEWSWIRE) — Pacific Software Inc. (“PFSF”) acquired certain assets of Dreamaderm Inc. (“Dreamaderm”) through a Plan of Acquisition, dated January 24, 2024. PFSF will now be the exclusive holder of a patented, first-in-class cosmeceutical asset, branded as Dermatrix. This groundbreaking technology boosts natural collagen production through a novel mechanism of action: preserving insulin within the skin. PFSF believes that Dermatrix will have broad utility for numerous dermatological applications, ranging from cosmetic treatments to acute and chronic wound care, and advanced medical aesthetics procedures. Dermatrix prevents...

Continue reading

Lincoln Educational Services Reports Continued Growth During First Quarter 2024, with 15% Student Starts and 20% Revenue Growth; Increasing Financial Guidance for Full Year 2024

Conference Call Today at 10 a.m. ET PARSIPPANY, N.J., May 06, 2024 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the first quarter ended March 31, 2024, as well as recent business developments. First Quarter 2024 Financial Highlights*Revenue grew 19.7% to $103.4 million Adjusted EBITDA tripled to $6.5 million Student starts increased 15.3% Ended quarter with 1,388 additional students, a 11.2% increase in population Total liquidity of over $109 million; no debt outstanding Increasing guidance for full year Revenue, Adjusted EBITDA and Adjusted Net IncomeRecent DevelopmentsClasses commenced at our newest campus in East Point, Georgia Entered into a 5-year agreement with Container Maintenance Corporation (“CMC”), (Marine Repair Services),...

Continue reading

Arqit Sets First Half 2024 Conference Call for Monday, May 20, 2024 at 11:00 a.m. ET

LONDON, May 06, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (“Arqit”), a leader in quantum safe encryption, announced it will report financial results for the six months ending March 31, 2024 on Monday, May 20, 2024. In conjunction with this announcement, Arqit will host a conference call at 11:00 a.m. ET / 8:00 a.m. PT on May 20, 2024 with the Company’s Founder, Chairman and CEO, David Williams, and CFO, Nick Pointon. A live webcast of the call will be available on the “News & Events” page of the Company’s website at ir.arqit.uk. To access the call by phone, please go to this link (registration link) and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a...

Continue reading

Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates

Net product revenue of $45.3 million in 1Q and $95.9 million since AugustFirst patient dosed in inhaled KB707 study for locally advanced or metastatic tumors of the lungReceived Fast Track Designations for both inhaled and intratumoral KB707Strong balance sheet with $622.3 million in cash and investments PITTSBURGH, May 06, 2024 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results and key business updates for the first quarter ending March 31, 2024. “With strong uptake of VYJUVEK and accelerating enrollment across our growing clinical pipeline, we made great progress this quarter on our mission to deliver transformational genetic medicines to patients with rare and serious diseases,” said Krish S. Krishnan, Chairman and CEO of Krystal...

Continue reading

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

Expect to share initial clinical and translational data from the Phase 1 trial of LYL797, a ROR1-targeted CAR T‑cell product candidate, this quarter On track to report initial clinical data from the Phase 1 trial of LYL845, an epigenetically enhanced TIL product candidate, in the second half of 2024 IND for second generation ROR1-targeted CAR T-cell product candidate on track for submission this quarter Cash, cash equivalents and marketable securities of $526.3 million as of March 31, 2024 supports advancing diverse pipeline through multiple clinical milestones into 2027SOUTH SAN FRANCISCO, Calif., May 06, 2024 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors today reported financial results...

Continue reading

The Children’s Place Reports Fourth Quarter and Full Year 2023 Results

SECAUCUS, N.J., May 06, 2024 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands with an industry-leading digital-first model, today announced financial results for the fourth quarter and fiscal year ended February 3, 2024. Fourth Quarter 2023 ResultsNet sales decreased $1.1 million, or 0.2%, to $455.0 million in the three months ended February 3, 2024, from $456.1 million in the three months ended January 28, 2023. The decrease in net sales compared to the fourth quarter 2022 was primarily due to reductions in retail sales due to lower store count and traffic declines to stores partially offset by continued strength in e-commerce.  Comparable retail sales increased 4.8% for the quarter. Gross profit and adjusted gross profit increased by $19.2 million to $98.9...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.